BETA: Please send your feedback!
GlaxoSmithKline
GSK-GB:LON
Pharmaceuticals: Major
$0
MEGA cap
$45.93
(-0.36%)
0.20%
since start of 2019
19.57
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Major
Founded 1999
GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.
website
Headquarters
Executives
| Name | Title | Gender |
| Simon Dingemans | Chief Financial Officer & Executive Director | Male |
| Philip Roy Hampton, MBA | Non-Executive Chairman | Male |
| Dan Troy | Senior Vice President & General Counsel | Male |
| Patrick J. T. Vallance, MD | Executive Director, President-R&D | Male |
| Claire Thomas | Senior Vice President-Human Resources | Female |
| Emma Walmsley | Chief Executive Officer & Executive Director | Female |
| Ziba Shamsi | Head-Investor Relations | Female |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
GlaxoSmithKline - Competitors and Related Companies
How GlaxoSmithKline stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.
GlaxoSmithKline
GSK-GB:LON
Pharmaceuticals: Major
$0
MEGA cap
$45.93
(-0.36%)
0.20%
since start of 2019
19.57
Novartis
NOVN-CH:SWX
Pharmaceuticals: Major
$58.77mm
MEGA cap
$2.20
(0.04%)
1.26%
since start of 2019
-2.18
Sanofi
SAN-FR:PAR
Pharmaceuticals: Major
$67.25bn
MEGA cap
$4.05
(0.16%)
-0.06%
since start of 2019
8.58
Shire
SHP-GB:LON
Pharmaceuticals: Major
—
LARGE cap
(—)
—
since start of 2019
—
Teva Pharmaceutical Industries
TEVA-IL:TAE
Pharmaceuticals: Generic
$10.70bn
LARGE cap
$9.80
(0.24%)
-0.36%
since start of 2019
-2.55
Dynavax Technologies
DVAX:NAS
Biotechnology
$580.35mm
SMALL cap
$6.92
(0.39%)
-0.21%
since start of 2019
-2.88